109 related articles for article (PubMed ID: 33516877)
1. 7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells.
Tanaka T; Saito H; Miyairi S; Kobayashi S
Biochem Biophys Res Commun; 2021 Mar; 544():15-21. PubMed ID: 33516877
[TBL] [Abstract][Full Text] [Related]
2. Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
Tanaka T; Ohashi S; Saito H; Wada T; Aoyama T; Ichimaru Y; Miyairi S; Kobayashi S
Biochem Biophys Res Commun; 2018 Jan; 496(1):7-11. PubMed ID: 29274785
[TBL] [Abstract][Full Text] [Related]
3. Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
Tanaka T; Kasai M; Kobayashi S
Exp Cell Res; 2018 Sep; 370(2):454-460. PubMed ID: 29981748
[TBL] [Abstract][Full Text] [Related]
4. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
[TBL] [Abstract][Full Text] [Related]
5. Four nucleocytoplasmic-shuttling proteins and p53 interact specifically with the YB-NLS and are involved in anticancer reagent-induced nuclear localization of YB-1.
Tanaka T; Ohashi S; Kobayashi S
Biochem Biophys Res Commun; 2016 Sep; 478(3):1363-9. PubMed ID: 27565728
[TBL] [Abstract][Full Text] [Related]
6. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
7. [Extracellular Y-box binding protein-1 promotes proliferation and metastasis of HepG2 cells through Notch3 receptor].
Shi J; Li P; Zou L; Chen P; Zhang LP
Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):202-6. PubMed ID: 27095764
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus.
Kretov DA; Mordovkina DA; Eliseeva IA; Lyabin DN; Polyakov DN; Joshi V; Desforges B; Hamon L; Lavrik OI; Pastré D; Curmi PA; Ovchinnikov LP
Cells; 2019 Dec; 9(1):. PubMed ID: 31906126
[TBL] [Abstract][Full Text] [Related]
9. Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma.
Liu Q; Tao T; Liu F; Ni R; Lu C; Shen A
Exp Cell Res; 2016 Dec; 349(2):230-238. PubMed ID: 27751836
[TBL] [Abstract][Full Text] [Related]
10. YB-1 Phosphorylation at Serine 209 Inhibits Its Nuclear Translocation.
Sogorina EM; Kim ER; Sorokin AV; Lyabin DN; Ovchinnikov LP; Mordovkina DA; Eliseeva IA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008856
[TBL] [Abstract][Full Text] [Related]
11. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.
Li D; Liu X; Zhou J; Hu J; Zhang D; Liu J; Qiao Y; Zhan Q
Hepatology; 2017 May; 65(5):1612-1627. PubMed ID: 28027578
[TBL] [Abstract][Full Text] [Related]
13. Stress-Induced Phosphorylation of Nuclear YB-1 Depends on Nuclear Trafficking of p90 Ribosomal S6 Kinase.
Tiwari A; Rebholz S; Maier E; Dehghan Harati M; Zips D; Sers C; Rodemann HP; Toulany M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126195
[TBL] [Abstract][Full Text] [Related]
14. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
[TBL] [Abstract][Full Text] [Related]
16. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.
Dai XY; Zhuang LH; Wang DD; Zhou TY; Chang LL; Gai RH; Zhu DF; Yang B; Zhu H; He QJ
Oncotarget; 2016 Feb; 7(6):6933-47. PubMed ID: 26771844
[TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
Yamashita T; Higashi M; Momose S; Morozumi M; Tamaru JI
Int J Oncol; 2017 Aug; 51(2):579-586. PubMed ID: 28714514
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
[TBL] [Abstract][Full Text] [Related]
19. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
[TBL] [Abstract][Full Text] [Related]
20. Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
Tao Z; Ruan H; Sun L; Kuang D; Song Y; Wang Q; Wang T; Hao Y; Chen K
Cancer Immunol Res; 2019 Jul; 7(7):1135-1147. PubMed ID: 31113805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
